Sangamo Therapeutics (SGMO) Receivables (2016 - 2025)
Historic Receivables for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $523000.0.
- Sangamo Therapeutics' Receivables fell 9744.83% to $523000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $523000.0, marking a year-over-year decrease of 9744.83%. This contributed to the annual value of $4.6 million for FY2024, which is 24886.88% up from last year.
- Per Sangamo Therapeutics' latest filing, its Receivables stood at $523000.0 for Q3 2025, which was down 9744.83% from $372000.0 recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Receivables registered a high of $20.5 million during Q3 2024, and its lowest value of $366000.0 during Q1 2025.
- In the last 5 years, Sangamo Therapeutics' Receivables had a median value of $4.6 million in 2024 and averaged $5.1 million.
- Per our database at Business Quant, Sangamo Therapeutics' Receivables soared by 107120.0% in 2024 and then crashed by 9744.83% in 2025.
- Over the past 5 years, Sangamo Therapeutics' Receivables (Quarter) stood at $6.4 million in 2021, then decreased by 29.36% to $4.5 million in 2022, then plummeted by 70.49% to $1.3 million in 2023, then skyrocketed by 248.87% to $4.6 million in 2024, then plummeted by 88.69% to $523000.0 in 2025.
- Its last three reported values are $523000.0 in Q3 2025, $372000.0 for Q2 2025, and $366000.0 during Q1 2025.